Loading...

NFL Biosciences SA

ALNFL.PA•EURONEXT
Healthcare
Biotechnology
€1.28
€0.08(6.84%)

NFL Biosciences SA (ALNFL.PA) Company Profile & Overview

Explore NFL Biosciences SA’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

NFL Biosciences SA (ALNFL.PA) Company Profile & Overview

NFL Biosciences SA, a biotechnology company, develops natural addiction withdrawal solutions for smokers. Its natural drug candidate in pipeline to cure tobacco addiction include NFL-101, a tobacco extract that is in Phase III clinical trial targeting smoking addiction; NFL-201, a cannabis and tobacco extract, which is in preclinical stage; and NFL-301, a botanical extract (traditional Chinese medicine) that is in preclinical stage. The company was incorporated in 2006 and is based in Castelnau-le-Lez, France.

SectorHealthcare
IndustryBiotechnology
CEOIgnacio Faus

Contact Information

https://www.nflbiosciences.com
33 4 11 93 76 67
199 Rue Helene Boucher, Castelnau-le-Lez, 34170

Company Facts

4 Employees
IPO DateJul 5, 2021
CountryFR
Actively Trading

Frequently Asked Questions

;